Read More Pharma Industry News What SL Bio’s Nasdaq debut reveals about biotech funding after the SPAC reset Find out how SL Bio’s Nasdaq listing could shape SLBT stock, off-the-shelf cell therapy and biotech SPAC sentiment today! bySoujanya RaviJune 15, 2026